Suppr超能文献

相似文献

1
Kidney cancer: opportunity for disease specific targeted therapy.
Urol Oncol. 2008 Sep-Oct;26(5):542. doi: 10.1016/j.urolonc.2008.03.014.
2
Editorial: Kidney cancer--a unique opportunity for the development of disease specific therapy.
J Urol. 2002 Dec;168(6):2411-2. doi: 10.1016/S0022-5347(05)64156-0.
3
Kidney Cancer Update The year in review in kidney cancer.
Clin Adv Hematol Oncol. 2015 May;13(5):327-9.
4
Kidney cancer: Combining targeted and immunotherapy.
Nat Rev Urol. 2018 May;15(5):263. doi: 10.1038/nrurol.2018.43. Epub 2018 Apr 5.
5
What do we need for eradicating kidney cancer cells?
Int J Urol. 2012 Feb;19(2):96-7. doi: 10.1111/j.1442-2042.2011.02899.x. Epub 2011 Dec 14.
6
Kidney cancer: neoadjuvant targeted therapies in renal cell carcinoma.
Nat Rev Urol. 2010 Feb;7(2):63-4. doi: 10.1038/nrurol.2010.2.
7
Kidney cancer: Low serum sodium linked to poor outcomes for patients with mRCC treated with targeted therapy.
Nat Rev Urol. 2013 Dec;10(12):679. doi: 10.1038/nrurol.2013.264. Epub 2013 Nov 12.
9
Management of small renal mass: an opportunity to address a growing problem in early stage kidney cancer.
Eur Urol. 2015 Sep;68(3):416-7. doi: 10.1016/j.eururo.2015.05.011. Epub 2015 May 21.

引用本文的文献

1
Targeting the Met signaling pathway in renal cancer.
Expert Rev Anticancer Ther. 2009 Jun;9(6):785-93. doi: 10.1586/era.09.43.

本文引用的文献

1
Surveillance for renal cell carcinoma: why and how? When and how often?
Urol Oncol. 2008 Sep-Oct;26(5):550-4. doi: 10.1016/j.urolonc.2007.05.026. Epub 2007 Dec 3.
2
Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma.
Urol Oncol. 2008 Sep-Oct;26(5):543-9. doi: 10.1016/j.urolonc.2008.03.012.
3
Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics.
Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):671s-679s. doi: 10.1158/1078-0432.CCR-06-1870.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验